chr1-241532484-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003679.5(KMO):āc.40A>Gā(p.Ile14Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000498 in 1,609,802 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003679.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KMO | NM_003679.5 | c.40A>G | p.Ile14Val | missense_variant | 1/15 | ENST00000366559.9 | NP_003670.2 | |
KMO | NM_001410944.1 | c.40A>G | p.Ile14Val | missense_variant | 1/15 | NP_001397873.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KMO | ENST00000366559.9 | c.40A>G | p.Ile14Val | missense_variant | 1/15 | 1 | NM_003679.5 | ENSP00000355517.4 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000246 AC: 61AN: 247558Hom.: 0 AF XY: 0.000261 AC XY: 35AN XY: 134032
GnomAD4 exome AF: 0.000514 AC: 749AN: 1457494Hom.: 0 Cov.: 30 AF XY: 0.000506 AC XY: 367AN XY: 725218
GnomAD4 genome AF: 0.000341 AC: 52AN: 152308Hom.: 0 Cov.: 33 AF XY: 0.000282 AC XY: 21AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.40A>G (p.I14V) alteration is located in exon 1 (coding exon 1) of the KMO gene. This alteration results from a A to G substitution at nucleotide position 40, causing the isoleucine (I) at amino acid position 14 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at